Floatz logo

Calcium folinate pentahydrate

Neurotoxicity

Alliance for Clinical Trials in OncologySmall moleculePhase 3Dormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Neurotoxicity cohort.

Asset / SponsorPhaseRating
METHOTREXATE
Radiation Therapy Oncology Group
Phase 2BB
Procarbazine
Radiation Therapy Oncology Group
Phase 2BB
ERIBULIN MONOMETHANESULFONATE
Oncologia Medica dell'Ospedale Fatebenefratelli
Phase 4BB
Eloxatin
Alliance for Clinical Trials in Oncology
Phase 3BB
MAGNESIUM METALLICUM
Alliance for Clinical Trials in Oncology
Phase 3BB

View all 49 →

Same molecule, other indications

Calcium folinate pentahydrate is also rated in:

Advanced KRAS Positive Metastatic Colorectal CancerDormant
BBB
Indicative ·
78 / 100
View asset →
Recurrent Pancreatic CarcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
Stage IV Colon CancerDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →